162 related articles for article (PubMed ID: 34769743)
21. Targeting Pyruvate Kinase M2 and Hexokinase II, Pachymic Acid Impairs Glucose Metabolism and Induces Mitochondrial Apoptosis.
Miao G; Han J; Zhang J; Wu Y; Tong G
Biol Pharm Bull; 2019 Jan; 42(1):123-129. PubMed ID: 30381614
[TBL] [Abstract][Full Text] [Related]
22. Pyruvate kinase: Function, regulation and role in cancer.
Israelsen WJ; Vander Heiden MG
Semin Cell Dev Biol; 2015 Jul; 43():43-51. PubMed ID: 26277545
[TBL] [Abstract][Full Text] [Related]
23. The Multifarious Functions of Pyruvate Kinase M2 in Oral Cancer Cells.
Kurihara-Shimomura M; Sasahira T; Nakashima C; Kuniyasu H; Shimomura H; Kirita T
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257458
[TBL] [Abstract][Full Text] [Related]
24. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.
Gao X; Wang H; Yang JJ; Liu X; Liu ZR
Mol Cell; 2012 Mar; 45(5):598-609. PubMed ID: 22306293
[TBL] [Abstract][Full Text] [Related]
25. Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics.
Zhu S; Guo Y; Zhang X; Liu H; Yin M; Chen X; Peng C
Cancer Lett; 2021 Apr; 503():240-248. PubMed ID: 33246091
[TBL] [Abstract][Full Text] [Related]
26. A Novel Role for Pyruvate Kinase M2 as a Corepressor for P53 during the DNA Damage Response in Human Tumor Cells.
Xia L; Wang XR; Wang XL; Liu SH; Ding XW; Chen GQ; Lu Y
J Biol Chem; 2016 Dec; 291(50):26138-26150. PubMed ID: 27810895
[TBL] [Abstract][Full Text] [Related]
27. Synergistic Allosteric Mechanism of Fructose-1,6-bisphosphate and Serine for Pyruvate Kinase M2 via Dynamics Fluctuation Network Analysis.
Yang J; Liu H; Liu X; Gu C; Luo R; Chen HF
J Chem Inf Model; 2016 Jun; 56(6):1184-1192. PubMed ID: 27227511
[TBL] [Abstract][Full Text] [Related]
28. Beta-elemene inhibits breast cancer metastasis through blocking pyruvate kinase M2 dimerization and nuclear translocation.
Pan Y; Wang W; Huang S; Ni W; Wei Z; Cao Y; Yu S; Jia Q; Wu Y; Chai C; Zheng Q; Zhang L; Wang A; Sun Z; Huang S; Wang S; Chen W; Lu Y
J Cell Mol Med; 2019 Oct; 23(10):6846-6858. PubMed ID: 31343107
[TBL] [Abstract][Full Text] [Related]
29. Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2.
Iqbal MA; Siddiqui FA; Gupta V; Chattopadhyay S; Gopinath P; Kumar B; Manvati S; Chaman N; Bamezai RN
Mol Cancer; 2013 Jul; 12():72. PubMed ID: 23837608
[TBL] [Abstract][Full Text] [Related]
30. Discovery of boronic acid-based potent activators of tumor pyruvate kinase M2 and development of gastroretentive nanoformulation for oral dosing.
Patle R; Shinde S; Patel S; Maheshwari R; Jariyal H; Srivastava A; Chauhan N; Globisch C; Jain A; Tekade RK; Shard A
Bioorg Med Chem Lett; 2021 Jun; 42():128062. PubMed ID: 33901643
[TBL] [Abstract][Full Text] [Related]
31. Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth.
Chiavarina B; Whitaker-Menezes D; Martinez-Outschoorn UE; Witkiewicz AK; Birbe R; Howell A; Pestell RG; Smith J; Daniel R; Sotgia F; Lisanti MP
Cancer Biol Ther; 2011 Dec; 12(12):1101-13. PubMed ID: 22236875
[TBL] [Abstract][Full Text] [Related]
32. Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase.
Ning X; Qi H; Li R; Li Y; Jin Y; McNutt MA; Liu J; Yin Y
Eur J Med Chem; 2017 Sep; 138():343-352. PubMed ID: 28688274
[TBL] [Abstract][Full Text] [Related]
33. Reciprocal regulation of protein kinase and pyruvate kinase activities of pyruvate kinase M2 by growth signals.
Gao X; Wang H; Yang JJ; Chen J; Jie J; Li L; Zhang Y; Liu ZR
J Biol Chem; 2013 May; 288(22):15971-9. PubMed ID: 23576436
[TBL] [Abstract][Full Text] [Related]
34. Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.
Chao TK; Huang TS; Liao YP; Huang RL; Su PH; Shen HY; Lai HC; Wang YC
PLoS One; 2017; 12(7):e0182166. PubMed ID: 28753677
[TBL] [Abstract][Full Text] [Related]
35. Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling.
Hsu MC; Hung WC
Mol Cancer; 2018 Feb; 17(1):35. PubMed ID: 29455645
[TBL] [Abstract][Full Text] [Related]
36.
Lai YJ; Chou YC; Lin YJ; Yu MH; Ou YC; Chu PW; Wu CC; Wang YC; Chao TK
Int J Environ Res Public Health; 2019 Nov; 16(23):. PubMed ID: 31756939
[TBL] [Abstract][Full Text] [Related]
37. Cancer metabolism meets systems biology: Pyruvate kinase isoform PKM2 is a metabolic master regulator.
Filipp FV
J Carcinog; 2013; 12():14. PubMed ID: 23961261
[TBL] [Abstract][Full Text] [Related]
38. OSU-A9 induced-reactive oxygen species cause cytotoxicity in duodenal and gastric cancer cells by decreasing phosphorylated nuclear pyruvate kinase M2 protein levels.
Chiu CF; Weng JR; Lee SL; Wu CY; Chu PC; Shan YS; Yang HR; Bai LY
Biochem Pharmacol; 2020 Apr; 174():113811. PubMed ID: 31954719
[TBL] [Abstract][Full Text] [Related]
39. Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis.
Li H; Xu H; Xing R; Pan Y; Li W; Cui J; Lu Y
Pathol Res Pract; 2019 Jun; 215(6):152409. PubMed ID: 31000383
[TBL] [Abstract][Full Text] [Related]
40. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]